1354 Anti-CCR8 antibody CHS-114 (SRF114) depletes tumor-infiltrating regulatory T cells in dissociated tumors from patients with head and neck squamous cell carcinoma

头颈部鳞状细胞癌 癌症研究 抗体 流式细胞术 肿瘤微环境 趋化因子 生物 免疫系统 免疫荧光 肿瘤进展 分子生物学 癌症 免疫学 头颈部癌 遗传学
作者
Robert R. Haines,Marisella Panduro,Yu Yang,Yue Ren,Vito J. Palombella,Jonathan A. Hill,Ricard Masia,James F. Mohan
标识
DOI:10.1136/jitc-2023-sitc2023.1354
摘要

Background

Depletion of intratumoral regulatory T cells (itTregs) represents an attractive therapeutic strategy to enhance anti-tumor responses. Transcriptional and flow cytometric analyses have identified the chemokine receptor CCR8 as being preferentially expressed on itTregs compared to peripheral Tregs and other immune cell types. Treatment of mouse tumor models with anti-CCR8 antibodies depletes itTregs, reduces tumor growth, and enhances anti-PD-1 anti-tumor activity in PD-1 resistant tumors. This highlights the therapeutic potential of anti-CCR8 depleting antibodies as a potential treatment for cancer patients and enhancing PD-1 therapy possibly in PD-1 resistant tumors. CHS-114 (formerly SRF114) is an afucosylated anti-CCR8 antibody designed to deplete human itTregs. Here, we evaluate the phenotype, frequency, and localization of CCR8+ Tregs within resected tumor samples from patients with head and neck squamous cell carcinoma (HNSCC) and other indications. We also examine CHS-114-mediated itTreg depletion, immune effector cell activation, and cytokine production in dissociated tumor cells (DTC) from HNSCC samples.

Methods

CCR8+ itTregs were characterized by flow cytometry and by immunofluorescence on formalin-fixed, paraffin-embedded (FFPE) samples. DTCs were cultured with CHS-114 to examine immune cell activation and itTreg depletion. The activity of anti-CCR8 treatment was assessed in humanized mice and the B16F10 tumor model.

Results

CCR8 expression in the tumor microenvironment is highly restricted to itTregs. Across several solid tumor types, >50% of itTregs are CCR8+ cells. Immunofluorescence on FFPE samples shows that CCR8+ itTregs predominantly localize in the stroma but can also be found within tumor nests. CCR8+ cells are also present within tertiary lymphoid structures (TLS) and therefore potentially involved in constraining TLS-mediated anti-tumor immune responses. HNSCC exhibited a high abundance and frequency of CCR8+ itTregs (>70%). CCR8+ itTreg levels correlated with PD-L1 status but not with disease stage or HPV status. Furthermore, HNSCC CCR8+ itTregs exhibited a highly activated phenotype indicated by increased expression of FOXP3, HLA-DR, and Ki-67 compared to CCR8- Tregs. SRF114 treatment of HNSCC DTC samples resulted in selective depletion of Tregs, NK cell activation, and IFNg production. In mouse models, CHS-114 and a murine surrogate exhibited potent CCR8+ Treg depletion in vivo, resulting in CD8+ T-cell expansion, activation of myeloid cells, and inhibition of tumor growth.

Conclusions

CHS-114 (SRF114) depletes CCR8+ Treg cells in vitro and in vivo. Molecular epidemiology studies highlight HNSCC as a tumor type with a high prevalence of CCR8+ itTregs to evaluate the anti-tumor activity of an anti-CCR8 antibody. CHS-114 (SRF114) is currently being evaluated in a Phase 1 clinical trial (NCT05635643).

Ethics Approval

All animal studies were conducted under a protocol approved by and in compliance with policies set by the Institutional Animal Care and Use Committee, protocol # 2023-SUR-03.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zheng完成签到 ,获得积分10
11秒前
一玮完成签到 ,获得积分10
11秒前
yeurekar完成签到,获得积分10
12秒前
柒月完成签到 ,获得积分10
12秒前
popo6150完成签到,获得积分10
16秒前
聪明的鹤完成签到 ,获得积分10
21秒前
小趴菜完成签到 ,获得积分10
21秒前
完美世界应助科研通管家采纳,获得10
21秒前
汤姆完成签到 ,获得积分10
22秒前
邹醉蓝完成签到,获得积分10
24秒前
暴躁的夏波完成签到 ,获得积分10
34秒前
35秒前
wangrong完成签到 ,获得积分10
35秒前
chichenglin完成签到 ,获得积分10
35秒前
时尚的梦曼完成签到,获得积分10
38秒前
匆匆赶路人完成签到 ,获得积分10
39秒前
六一儿童节完成签到 ,获得积分10
39秒前
粗心的荷花完成签到 ,获得积分10
41秒前
tmobiusx完成签到,获得积分10
42秒前
三脸茫然完成签到 ,获得积分10
44秒前
令狐新竹完成签到 ,获得积分10
44秒前
51秒前
ghost完成签到 ,获得积分10
53秒前
blissche完成签到 ,获得积分10
54秒前
t铁核桃1985完成签到 ,获得积分10
1分钟前
l老王完成签到 ,获得积分10
1分钟前
饱满的大碗完成签到 ,获得积分10
1分钟前
Bismarck完成签到,获得积分10
1分钟前
微笑高山完成签到 ,获得积分10
1分钟前
张若旸完成签到 ,获得积分10
1分钟前
leo完成签到,获得积分10
1分钟前
何博士完成签到 ,获得积分10
1分钟前
朱奕韬完成签到,获得积分10
1分钟前
1分钟前
坦率无剑完成签到,获得积分10
1分钟前
思源应助朱奕韬采纳,获得10
1分钟前
活泼的寒安完成签到 ,获得积分10
1分钟前
蚂蚁踢大象完成签到 ,获得积分10
1分钟前
蔡从安完成签到,获得积分20
1分钟前
楚襄谷完成签到 ,获得积分10
1分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146856
求助须知:如何正确求助?哪些是违规求助? 2798171
关于积分的说明 7826733
捐赠科研通 2454724
什么是DOI,文献DOI怎么找? 1306446
科研通“疑难数据库(出版商)”最低求助积分说明 627788
版权声明 601565